Human antibody combinations determined by epitope mapping of orthopoxvirus A33/A35 confer therapeutic protection in mice
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Combinations of mAbs targeting nonoverlapping epitopes mediated synergistic, Fc-dependent neutralization in vitro; conferred therapeutic protection against lethal VACV challenge; and reduced viral burden and disease severity after MPXV challenge in mice.
Appeared: Friday, November 13. Science Translational Medicine. Peer-reviewed journal.